LIAN BRIAN (President & CEO) sold 8.6% of their position (216.13K shares) of VIKING THERAPEUTICS, INC. on the open market
Open‑market sale worth $15.31M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock, par value $0.00001 per share
Shares
+166.13K
Price / share
$7.77
Trade value
$1.29M
% of position
Common Stock, par value $0.00001 per share
Shares
−96.06K
Price / share
$70.43
Trade value
$6.77M
% of position
Common Stock, par value $0.00001 per share
Shares
−119.87K
Price / share
$71.15
Trade value
$8.53M
% of position
Common Stock, par value $0.00001 per share
Shares
−200.00
Price / share
$71.98
Trade value
$14.40K
% of position
Net shares
−50K
Net value
-$14.02M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.00001 per share Direct | 9/20/2024 | M · Option Exercise | +166.13K | $7.77 | $1.29M | 7.1% | 2.35M | 2.52M |
| Common Stock, par value $0.00001 per share Direct | 9/20/2024 | S · Sale | −96.06K | $70.43 | $6.77M | 3.8% | 2.52M | 2.43M |
| Common Stock, par value $0.00001 per share Direct | 9/20/2024 | S · Sale | −119.87K | $71.15 | $8.53M | 4.9% | 2.43M | 2.31M |
| Common Stock, par value $0.00001 per share Direct | 9/20/2024 | S · Sale | −200.00 | $71.98 | $14.40K | 0.0% | 2.31M | 2.30M |
| Total | −50K | -$14.02M | ||||||
Stock Option (Right to Buy)
Common Stock
166.13K shares
Shares
−166.13K
Strike price
7.77
Held after
65K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock166.13K shares | 9/20/2024 | M · Option Exercise | −166.13K | 7.77 | — | 65K |